Companies: 10,795·Total market cap: $144.5T
Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNNNASDAQHealthcare● Active
$17.22
$-5.77(-25.10%)
Market Cap$755806464
P/E Ratio
52W High$55.65
52W Low$7.92
Overview

Anbio Biotechnology Class A Ordinary Shares(NNNN)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NNNN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.22nnnn eps ttm · nnnn earnings per shareEarnings history
PE Ratio (TTM)76.8×nnnn pe ratio ttm · nnnn price to earningsPE Ratio deep dive
Revenue (TTM)$18.6Mnnnn revenue ttm · nnnn annual revenueFull revenue history
Dividend Yield不分红does nnnn pay dividends · nnnn dividend yieldDividend history
Shares Outstanding43.9Mnnnn shares outstanding · nnnn floatShares outstanding history
Next EarningsTBAnnnn earnings date · nnnn next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$9.8M▲ +19.22% YoY
202320242025
anbio biotechnology class a ordinary shares revenue · nnnn revenue 2025
FY 2025Net Income$7.2M▲ +204.56% YoY
202320242025
anbio biotechnology class a ordinary shares net income · nnnn profit 2025
FY 2025EPS$0.16▲ +185.71% YoY
202320242025
nnnn eps · anbio biotechnology class a ordinary shares earnings per share 2025
TTM:Revenue: $18.6MNet Income: $9.7MEPS: $0.22View income statement →

股票表现

完整历史
1D-25.10%
1W-44.42%
1M-33.36%
3M-24.77%
YTD-42.73%
1Y+104.51%
5Y+198.44%

关于 Anbio Biotechnology Class A Ordinary Shares

CEOMichael Lau
IPO DateFeb 19, 2025
Employees27
CountryDE
Websiteanbio.com

Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers reg…

what is anbio biotechnology class a ordinary shares · nnnn stock overview · anbio biotechnology class a ordinary shares company profile · who is anbio biotechnology class a ordinary shares ceo · nnnn NASDAQ · anbio biotechnology class a ordinary shares headquarters · anbio biotechnology class a ordinary shares business segments

关于股票概览与关键数据

Anbio Biotechnology Class A Ordinary Shares(NNNN)是 Medical - Instruments & Supplies 行业的 Healthcare 类公司,于 Feb 19, 2025 在 NASDAQ 上市。截至最近交易日,NNNN 股价为 $17.22,市值约为 $755.8M。过去12个月累计回报 +104.51%,年初至今回报 -42.73%。

2025 财年 Anbio Biotechnology Class A Ordinary Shares 营收 $9.8M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Anbio Biotechnology Class A Ordinary Shares(NNNN)股价为 $17.22,在 NASDAQ 上市,52周区间为 $7.92 – $55.65。

NNNN 最新股价NNNN quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议